1. Home
  2. MVO vs DBVT Comparison

MVO vs DBVT Comparison

Compare MVO & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MVO
  • DBVT
  • Stock Information
  • Founded
  • MVO 2006
  • DBVT 2002
  • Country
  • MVO United States
  • DBVT France
  • Employees
  • MVO N/A
  • DBVT N/A
  • Industry
  • MVO Oil & Gas Production
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MVO Energy
  • DBVT Health Care
  • Exchange
  • MVO Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • MVO 95.7M
  • DBVT 102.0M
  • IPO Year
  • MVO N/A
  • DBVT N/A
  • Fundamental
  • Price
  • MVO $5.98
  • DBVT $7.98
  • Analyst Decision
  • MVO
  • DBVT Strong Buy
  • Analyst Count
  • MVO 0
  • DBVT 2
  • Target Price
  • MVO N/A
  • DBVT $22.50
  • AVG Volume (30 Days)
  • MVO 55.1K
  • DBVT 1.2M
  • Earning Date
  • MVO 01-01-0001
  • DBVT 05-06-2025
  • Dividend Yield
  • MVO 17.46%
  • DBVT N/A
  • EPS Growth
  • MVO N/A
  • DBVT N/A
  • EPS
  • MVO 1.46
  • DBVT N/A
  • Revenue
  • MVO N/A
  • DBVT $4,151,000.00
  • Revenue This Year
  • MVO N/A
  • DBVT $1,679.52
  • Revenue Next Year
  • MVO N/A
  • DBVT $535.67
  • P/E Ratio
  • MVO $7.29
  • DBVT N/A
  • Revenue Growth
  • MVO N/A
  • DBVT N/A
  • 52 Week Low
  • MVO $8.85
  • DBVT $0.44
  • 52 Week High
  • MVO $13.95
  • DBVT $8.50
  • Technical
  • Relative Strength Index (RSI)
  • MVO 55.09
  • DBVT 64.55
  • Support Level
  • MVO $5.52
  • DBVT $7.00
  • Resistance Level
  • MVO $6.09
  • DBVT $7.80
  • Average True Range (ATR)
  • MVO 0.40
  • DBVT 0.96
  • MACD
  • MVO 0.05
  • DBVT 0.07
  • Stochastic Oscillator
  • MVO 73.33
  • DBVT 81.09

About MVO MV Oil Trust Units of Beneficial Interests

MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These oil and gas properties include producing oil and gas wells.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: